XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Investments:    
Equity securities, at fair value (cost: $1,563 and $1,926) $ 185 $ 680
Cash and cash equivalents 1,409 495
Restricted cash and cash equivalents 3,412 3,250
Premiums receivable 1,365 977
Other investments 541 2,478
Loan receivable 100
Due from related party 63 63
Deferred policy acquisition costs 175 101
Operating lease right-of-use assets 100 9
Prepayment and other assets 72 96
Property and equipment, net 1 4
Total assets 7,323 8,253
Liabilities and Shareholders’ Equity    
Notes payable to noteholders 118 118
Notes payable to Epsilon / DeltaCat Re Tokenholders 1,485 1,523
Unearned premium reserve 1,586 915
Operating lease liabilities 100 9
Accounts payable and other liabilities 383 356
Total liabilities 3,672 2,921
Shareholders’ equity:    
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 6,150,556 and 5,870,234 shares issued and outstanding) 6 6
Additional paid-in capital 33,325 32,740
Accumulated deficit (29,680) (27,414)
Total shareholders’ equity 3,651 5,332
Total liabilities and shareholders’ equity $ 7,323 $ 8,253